Navigation Links
EaglePicher Medical Power Announces New Li/CFx Battery Technology
Date:5/11/2009

Enhanced design now features End-of-Life capability and longer life

PLANO, Texas, May 11 /PRNewswire/ -- EaglePicher Medical Power, LLC, a leading supplier of batteries for implantable medical devices, today announced the introduction of its enhanced Lithium Carbon Monofluoride (Li/CFx) battery technology with end-of-life capability superior to currently available products in the market. The technology includes a proprietary new Elective Replacement Indicator (ERI) / End of Life (EOL) Indicator to accurately predict battery depletion six months in advance, potentially requiring fewer replacement surgeries over time.

"This enhanced chemistry delivers several benefits - to device manufacturers, physicians and patients. In addition to the new end-of-life feature, this proprietary chemistry provides superior energy density for longer battery life," said Joe Marotta, vice president and general manager of EaglePicher Medical Power. "It gives us great pride to announce a technology that will help improve the lives of patients who rely on implantable medical devices."

The enhanced Li/CFx battery chemistry provides higher energy density for use in a variety of implantable applications including telemetry-capable pacemakers and ICDs, neurostimulation devices, drug pumps, body fluid pumps and monitors.

Benefits include:

  • Proprietary ERI/EOL indicator for safe and predictable replacement prior to end of battery life
  • Superior energy density enabling longer life or potentially smaller devices
  • Excellent rate capability for rapid capacitor charging throughout most of the battery life
  • Telemetry capability
  • Elimination of the initial voltage delay commonly seen in Li/CFx batteries
  • Low self-discharge

The new technology will be available in a number of configurations ranging from under 350 mAh to 10 Ah.

For more information about EaglePicher Medical Power and the new Li/CFx technology, please visit the company's exhibit (booth #1471) at this week's Heart Rhythm 2009 conference and exhibition in Boston.

About EaglePicher Medical Power

Headquartered in Plano, Texas, EaglePicher Medical Power, LLC is an EaglePicher company and a world-leading supplier of batteries to manufacturers of implantable medical devices. Products include batteries for cardio defibrillators, heart monitors, heart re-synchronizers and neuromodulation systems.

EaglePicher Medical Power, one of the few producers of implantable-grade batteries in the world to be certified ISO 13485, leads the industry in producing rechargeable lithium-ion batteries for implantable applications. Building upon the world-class technology heritage of parent EaglePicher, the company offers one of the broadest ranges of electrochemistries for implantable applications including lithium-ion, lithium manganese dioxide, lithium thionyl chloride and lithium carbon monofluoride.


'/>"/>
SOURCE EaglePicher Medical Power, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. EaglePicher Medical Power Names Joseph Marotta Vice President of Sales and Marketing
2. EaglePicher Technologies Introduces First Implantable Medical Cell Designed Specifically for Monitoring Applications
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Celebrates Successful First Year
5. New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board
6. Optasia Medical, Ltd. Achieves ISO 9001 and ISO 13485 Certification
7. Palomar Medical to Market Quantels SINON Tattoo Removal Laser in the United States and Canada
8. The EntreTech Forum Presents ... PHOTONICS/OPTICS - Understanding the Latest Applications of Light-based Technologies in Medical, Consumer, Industrial, and Defense Sectors
9. AMPM to Provide Medical Billing Services for Seton Community Health Centers in Austin
10. 7 of 10 women are uninsured or underinsured, or have medical bill, debt, access problems
11. 100% Invisible Lyric(R) Hearing Aid Wins Medical Design Excellence Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... While new U.S. opioid ... physicians are not legally required to follow them. In the absence of federal ... Novus Medical Detox Center , a leading Florida-based drug treatment facility, strongly ...
(Date:5/23/2016)... ... ... the upcoming airing of Innovations with Ed Begley, Jr., ... 4:00pET via Fox Business. , The show will explore ... safely and rapidly develop cures for mosquito-borne, emerging infectious ...
(Date:5/23/2016)... , ... May 23, 2016 ... ... Size for Verification and Validation:, Tools to Safely Speed Your Device to ... http://www.fdanews.com/bestdevicesamplesizevv                  , Today's FDA inspectors focus like lasers on device ...
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... ... the action analytics leader as Chief Medical Officer. Dr. O’Connor’s deep expertise in ... product development and client services teams who deliver best-in-class solutions and transformative technologies ...
(Date:5/23/2016)... Valley, California (PRWEB) , ... May 23, 2016 ... ... clinical communications and solutions for healthcare providers announced today that AGNITY MobileCare™ Platform ... and health collaboration applications as a part of its M-Health Solution. Tech Mahindra ...
Breaking Medicine News(10 mins):
(Date:5/19/2016)... Israel , May 19, 2016 ... the "Company"), an emerging global ophthalmic company focused on ... candidates which address ophthalmic conditions, announced today that it ... Italy ) for the manufacturing, distribution, marketing ... for the treatment of dry eye syndrome (DES) and ...
(Date:5/19/2016)... May 19, 2016 A ... World Biopsy Devices Market Opportunities and Forecasts, 2014 ... market generated $1,621 million in 2015. The MRI-guided ... and is expected to maintain this trend over ... http://photos.prnewswire.com/prnh/20140911/647229 ) , To know ...
(Date:5/19/2016)... BioLineRx Ltd. (NASDAQ/TASE: BLRX) announced ... of multiple cancer and hematological indications, will be presented ... titled " Clinical response in relapsed/refractory AML patients correlates ... a potent CXCR4 antagonist; results of a Phase 2a ... the European Hematology Association 21st Congress, to be held ...
Breaking Medicine Technology: